New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways
Molecular Diversity · 2025
DOI: 10.1007/s11030-025-11368-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Xiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Triazoles, Janus Kinase 1, Colitis, Ulcerative. Die Arbeit nennt 18 Literaturangaben. Gefördert von: the Scientific Research Fund Project of Yunnan Education Department, the Open Project of Key Laboratory of Dai and Yi Medicines of Yunnan Province.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic, nonspecific inflammatory bowel disease that is very difficult to cure. In this study, we have designed and synthesized a series of new 1,2,3-triazole-linked (±)-Agrimonolide derivatives and evaluated their anti-inflammatory activities. The in vitro results demonstrated that most triazole derivatives effectively inhibited NO production, and most compounds exhibited better anti-inflammatory activity than that of (±)-Agrimonolide and positive drug Dexamethasone. The further in vivo tests indicated that 6d could inhibit the release of inflammatory mediators in the colon tissue and alleviate Ulcerative colitis by inhibiting JAK1/STAT3 pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China.
- School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China.
- Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. lyp8691@163.com.
- School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China. lyp8691@163.com.
- Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, 650500, China. wanchunping1012@163.com.
- School of Chinese Materia Medica, School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, 650500, China. wanchunping1012@163.com.
Förderung
- the Scientific Research Fund Project of Yunnan Education Department
- the Open Project of Key Laboratory of Dai and Yi Medicines of Yunnan Province
Zitieren
APA
Zhang, X., Ju, M. Q., Yang, H. L., Zhang, C. F., Huang, M. K., Li, Y. P., Wan, C. P., & Mao, Z. W. (2025). New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways. Molecular Diversity. https://doi.org/10.1007/s11030-025-11368-3
Vancouver
Zhang X, Ju MQ, Yang HL, Zhang CF, Huang MK, Li YP, et al. New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways. Molecular Diversity. 2025. doi:10.1007/s11030-025-11368-3
BibTeX
@article{Zhang2025,
author = {Zhang, Xiao and Ju, Ming-Qian and Yang, Heng-Li and Zhang, Chun-Fei and Huang, Mao-Kui and Li, Yan-Ping and Wan, Chun-Ping and Mao, Ze-Wei},
title = {New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-025-11368-3}
}
EUVIMED